InVivo Therapeutics (NVIV.OB +19.9%) rises sharply on heavy volume after announcing the FDA has approved its request for a Humanitarian Use Device designation for its biopolymer scaffolding product. The designation should help the company speed the product to market. A clinical trial submission is being reviewed by the FDA currently.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs